Pfizer on a Quest to Acquire AstraZeneca and General Electric Makes $17B Bid for Alstom SA

Pfizer Inc. (NYSE: PFE) CEO Ian Read is in London urging ministers to back his company's proposed takeover of AstraZeneca (AZN). Read has told the Financial Times that any move to preserve a smaller U.K. “national champion” would be misguided. Pfizer recently revealed that the company is preparing a £60billion bid for AstraZeneca, who produces drugs combating diabetes, high cholesterol and cancer for millions of patients. AstraZeneca has already rejected two offers from Pfizer this year remarking that the bids were  ‘very significantly undervalued AstraZeneca and its prospects’. Pfizer